Fig. 5From: Immune-related lncRNA classification of head and neck squamous cell carcinoma Immunotherapeutic response and identification of predictive classifier. a C2 may be more response to the PD-1 inhibitor (nominal and Bonferroni corrected P < 0.05) by SubMap analysis in training and validation cohort. b Concordance of HNSCC subtypes prediction between original classification based on NMF and the 31-lncRNA classifierBack to article page